wuming7890
Lv1
40 积分
2022-02-04 加入
-
Comparative efficacy and safety of secukinumab 75 mg, 150 mg, and 300 mg in patients with active ankylosing spondylitis
15天前
已完结
-
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
1个月前
已完结
-
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study
2个月前
已完结
-
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study
2个月前
已完结
-
Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry
2个月前
已完结
-
Positioning therapies for the management of inflammatory bowel disease
3个月前
已完结
-
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross‐validation study against amyloid PET
3个月前
已完结
-
Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
3个月前
已完结
-
Psoriasis: rationale for targeting interleukin-17
3个月前
已完结
-
Interleukin-17 and Type 17 Helper T Cells
3个月前
已完结